Clinical trial
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00396305 |
|---|---|
| Title | Th1 Response to Influenza: Aging and Vaccine Efficacy |
| Official title | Th1 Response to Influenza: Aging and Vaccine Efficacy |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological, Drug |
| Interventions | Placebo, Trivalent Inactivated Influenza |
| Enrollment | 41 |
| Start date | Nov 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Nov 6, 2006 |
| Last update posted | Aug 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: